Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Treatment Acute Myeloid Leukemia Using Cytoreductive Chemotherapy Cytarabine (Ara-C) Followed Azacitidine (AZA) Maintenance: A Real Life Single Center Experience

Rosa Greco, MD, Annamaria Petrungaro, Anna Grazia Recchia, Laura De Stefano, Sabrina Bossio, Angela Palummo, Giovanni Iaquinta, Francesca Storino, Nadia Caruso, Massimo Gentile, MD, Antonino Neri, MD, Ernesto Vigna, Fortunato Morabito

Blood (2016) 128 (22): 5204.

https://doi.org/10.1182/blood.V128.22.5204.5204

Published: 2016

Journal Articles

Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients

Blood (2016) 128 (16): 2093–2095.

https://doi.org/10.1182/blood-2016-07-728261

Published: 2016

Includes: Supplemental data

Journal Articles

Microenvironment Regulation of IL23R/IL-23 Axis Drives Chronic Lymphocytic Leukemia (CLL) Progression

Fortunato Morabito, MD, Giovanna Cutrona, PhD, Anna Grazia Recchia, PhD, Marina Fabbi, Silvano Ferrini, Massimo Gentile, MD, Ernesto Vigna, Monica Colombo, Carlotta Massucco, MS, Sabrina Bossio, Laura De Stefano, Ugo Consoli, MD, Iolanda D. Vincelli, Caterina Musolino, Stefano Molica, MD, Antonino Neri, MD, Claudio Tripodo, MD, Manlio Ferrarini, MD

Blood (2015) 126 (23): 616.

https://doi.org/10.1182/blood.V126.23.616.616

Published: 2015

Journal Articles

Differentially Expressed Protein Patterns in Chronic Lymphocytic Leukemia (CLL) after Thymosin beta4 (Tb4) and Lenalidomide (Len) Treatment: Two-Dimensional Gel Electrophoresis (2DE) Analysis

Sabrina Bossio, Laura De Stefano, Mariavaleria Pellicanò, PhD, Angela Palummo, Francesca Storino, Nadia Caruso, Giovanni Iaquinta, Giovanna Cutrona, PhD, Massimo Gentile, MD, Ernesto Vigna, Anna Grazia Recchia, PhD, Fortunato Morabito, MD, Antonino Neri, MD

Blood (2015) 126 (23): 1729.

https://doi.org/10.1182/blood.V126.23.1729.1729

Published: 2015

Journal Articles

A Comprehensive Progression Risk Score to Predict Treatment Free Survival for Early Stage Chronic Lymphocytic Leukemia Patients

Blood (2015) 126 (23): 2930.

https://doi.org/10.1182/blood.V126.23.2930.2930

Published: 2015

Journal Articles

On the Absence of Calreticulin (CALR) Mutations in Chronic Myeloprolierative Neoplasms (MPNs) with Splanchnic Venous Thrombosis (SVT): Experience from a Single Institution

Bruno Martino, MD, Corrado Mammì, MD, Claudia Labate, Martino Enrica Antonia, MD, Francesca Ronco, MD, Anna Grazia Recchia, Domenica Ielo, Caterina Alati, MD, Esther Oliva, MD, Carmelo Laganà, Fortunato Morabito, MD

Blood (2014) 124 (21): 3198.

https://doi.org/10.1182/blood.V124.21.3198.3198

Published: 2014

Journal Articles

Insulin Growth Factor 1 Receptor Expression Is Associated with NOTCH1 Mutation, Trisomy 12 and Aggressive Clinical Course in Chronic Lymphocytic Leukemia

Blood (2014) 124 (21): 3314.

https://doi.org/10.1182/blood.V124.21.3314.3314

Published: 2014

Journal Articles

Stereotyped Subset #4 In Chronic Lymphocytic Leukemia Is Associated With Distinct Gene and Microrna Transcriptional Profile

Blood (2013) 122 (21): 1616.

https://doi.org/10.1182/blood.V122.21.1616.1616

Published: 2013

Journal Articles

High-Throughput Sequencing For The Identification Of NOTCH1 mutations In Early Stage Chronic Lymphocytic Leukemia: Biological and Clinical Implications

Blood (2013) 122 (21): 1622.

https://doi.org/10.1182/blood.V122.21.1622.1622

Published: 2013

Journal Articles

The Pro-Inflammatory IL23/IL23R/IL17 Axis Is Active in IL23R-Expressing Circulating CLL Cells in Patients with Poor Prognosis

Fortunato Morabito, MD, Giovanna Cutrona, PhD, Anna Grazia Recchia, PhD, Sonia Fabris, PhD, Serena Matis, PhD, Monica Colombo, PhD, Sabrina Bossio, Massimo Gentile, MD, Carlotta Massucco, PhD, Laura De Stefano, Stefano Molica, MD, Caterina Musolino, MD, Fiorella Ilariucci, Gianluca Festini, MD, Francesco Di Raimondo, MD, Pierfrancesco Tassone, MD, Antonino Neri, Claudio Tripodo, MD, Manlio Ferrarini, MD

Blood (2012) 120 (21): 3889.

https://doi.org/10.1182/blood.V120.21.3889.3889

Published: 2012

Journal Articles

The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia

Fortunato Morabito, Rosaria De Filippi, Luca Laurenti, Katja Zirlik, Anna Grazia Recchia, Massimo Gentile, Emanuela Morelli, Ernesto Vigna, Vincenzo Gigliotti, Rosa Calemma, Barbara Amoroso, Antonino Neri, Giovanna Cutrona, Manlio Ferrarini, Stefano Molica, Giovanni Del Poeta, Claudio Tripodo, Antonio Pinto

Blood (2011) 118 (24): 6353–6361.

https://doi.org/10.1182/blood-2011-04-345587

Published: 2011

Includes: Supplemental data

Journal Articles

Analysis of Stereotyped IGHV Distribution In a Series of 1133 Chronic Lymphocytic Leukemia Patients: The Experience of a Multicenter Italian Study Group

Francesco Maura, Giovanna Cutrona, PhD, Massimo Gentile, Serena Matis, PhD, Monica Colombo, Luca Agnelli, Giacomo Tuana, Rosanna Massara, Fabrizio Loiacono, Simona Pedemonte, Daniele Reverberi, Emanuela Anna Pesce, Marta Lionetti, PhD, Sonia Fabris, PhD, Anna Grazia Recchia, Francesco Di Raimondo, MD, Caterina Musolino, MD, Marco Gobbi, Nicola Di Renzo, MD, Francesca Romana Mauro, Renato Cantaffa, Maura Brugiatelli, MD, Francesco Merli, MD, Simonetta Zupo, Caterina Mammi, Luca Baldini, Francesco Angrilli, MD, Gianni Quintana, Ugo Consoli, MD, Giovanni Bertoldero, MD, Emilio Iannitto, MD, Paolo Di Tonno, Antonio Fragasso, Stefano Molica, MD, Pellegrino Musto, MD, Maria Cristina Cox, Gianluca Festini, Vincenzo Callea, MD, Stefano Sacchi, Giorgio Lambertenghi Deliliers, MD, Robin Foà, MD, Massimo Federico, MD, Agostino Cortelezzi, MD, Fortunato Morabito, Manlio Ferrarini, Antonino Neri, MD

Blood (2010) 116 (21): 2423.

https://doi.org/10.1182/blood.V116.21.2423.2423

Published: 2010

Journal Articles

The Total Amount of Kappa Plus Lambda Serum Immunoglobulin Free Light Chains (sFLC κ+λ) Is a Powerful Independent Predictor of Time to First Treatment In Chronic Lymphocytic Leukemia (CLL) and Allows Definition of a Novel Prognostic Scoring System: A Study of 449 Therapy-naïve Patients

Fortunato Morabito, MD, Rosaria De Filippi, MD, PhD, Luca Laurenti, MD, Katja Zirlik, MD, Anna Grazia Recchia, PhD, Massimo Gentile, MD, Emanuela Morelli, MD, Solluzzo Cavalcanti, MD, Giancarla Iaccarino, D.Sci, Barbara Amoroso, MD, PhD, Antonino Neri, MD, Giovanna Cutrona, PhD, Manlio Ferrarini, MD, Stefano Molica, MD, Giovanni Del Poeta, MD, Antonio Pinto, MD

Blood (2010) 116 (21): 2437.

https://doi.org/10.1182/blood.V116.21.2437.2437

Published: 2010

Journal Articles

Simultaneous Detection of Genomic Rearrangements In Myelodysplastic Syndromes (MDS) with the Multiplex Ligation-Dependent Probe Amplification (MLPA) Assay

Oronzo Scarciolla, MD, PhD, Alberto Fragasso, MD, Clara Mannarella, MD, Angela Ciancio, MD, Rosa Anna Cifarelli, Massimo Gentile, MD, Catia Dininno, Carla Mazzone, MD, Anna Grazia Recchia, PhD, Pasquale Servillo, Ernesto Vigna, MD, Paola Casieri, Lisa Anelli, Fortunato Morabito, MD, Giorgina Specchia, MD

Blood (2010) 116 (21): 1863.

https://doi.org/10.1182/blood.V116.21.1863.1863

Published: 2010

NARROW

Treatment Acute Myeloid Leukemia Using Cytoreductive Chemotherapy Cytarabine (Ara-C) Followed Azacitidine (AZA) Maintenance: A Real Life Single Center Experience

Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients

Microenvironment Regulation of IL23R/IL-23 Axis Drives Chronic Lymphocytic Leukemia (CLL) Progression

Differentially Expressed Protein Patterns in Chronic Lymphocytic Leukemia (CLL) after Thymosin beta4 (Tb4) and Lenalidomide (Len) Treatment: Two-Dimensional Gel Electrophoresis (2DE) Analysis

A Comprehensive Progression Risk Score to Predict Treatment Free Survival for Early Stage Chronic Lymphocytic Leukemia Patients

On the Absence of Calreticulin (CALR) Mutations in Chronic Myeloprolierative Neoplasms (MPNs) with Splanchnic Venous Thrombosis (SVT): Experience from a Single Institution

Insulin Growth Factor 1 Receptor Expression Is Associated with NOTCH1 Mutation, Trisomy 12 and Aggressive Clinical Course in Chronic Lymphocytic Leukemia

Stereotyped Subset #4 In Chronic Lymphocytic Leukemia Is Associated With Distinct Gene and Microrna Transcriptional Profile

High-Throughput Sequencing For The Identification Of NOTCH1 mutations In Early Stage Chronic Lymphocytic Leukemia: Biological and Clinical Implications

The Pro-Inflammatory IL23/IL23R/IL17 Axis Is Active in IL23R-Expressing Circulating CLL Cells in Patients with Poor Prognosis

The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia

Analysis of Stereotyped IGHV Distribution In a Series of 1133 Chronic Lymphocytic Leukemia Patients: The Experience of a Multicenter Italian Study Group

The Total Amount of Kappa Plus Lambda Serum Immunoglobulin Free Light Chains (sFLC κ+λ) Is a Powerful Independent Predictor of Time to First Treatment In Chronic Lymphocytic Leukemia (CLL) and Allows Definition of a Novel Prognostic Scoring System: A Study of 449 Therapy-naïve Patients

Simultaneous Detection of Genomic Rearrangements In Myelodysplastic Syndromes (MDS) with the Multiplex Ligation-Dependent Probe Amplification (MLPA) Assay

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only